Iv0024 is a humanized monoclonal antibody designed to block interleukin-9 (IL-9), a cytokine produced by T helper 9 (Th9) cells that promotes mast cell growth, mucus production, and airway inflammation. By targeting IL-9, Iv0024 may help modulate immune responses in conditions such as asthma by reducing mast cell–mediated effects.
Protein A/G purified from cell culture supernatant.
Accession
P15248
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Caption
Flow-cytometry using anti-human IL9 antibody.IL9 Transfected CHO cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IL9 antibody monoclonal antibody (Catalog No.:TD-HB771010 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-mouse antibody (Catalog No.:TD-MF690414) and cells analysed on a NovoCyte Flow Cytometer. | SDS-PAGE for InVivoMAb Anti-Human IL9 (Iv0024).
Note
For research use only. Not suitable for clinical or therapeutic use.